DBV Technologies S.A. (DBVT)
Data as of , from SEC Form 4 filings.
See up to 3 months of DBVT. The 7-day demo opens the 1M and 3M ranges and puts DBVT on your watchlist.
Start 7-day demoLatest DBVT insider trades
About DBV Technologies S.A. (DBVT)
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
- CHATILLON, I0
- 170
- 2014
- XNAS
https://www.dbv-technologies.comSEC filings for DBVT on EDGAR
DBVT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 464 | $1K |
DBVT insider transactions (Form 4)
2412 Form 4 filings on record, the earliest from Nov 25, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 464 | $2.70 footnote F3 | $1K | |
| ||||||
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 534 footnote F3 | $4.86 | $3K | |
| ||||||
| BAKER BROS. ADVISORS LP | Option exercise | BS Warrant | 2,299,656 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Option exercise | BS Warrant | 25,005,240 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Option exercise | Second Pre-Funded Warrant | 2,299,656 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Option exercise | Second Pre-Funded Warrant | 25,005,240 | $0.00 | - | |
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 6,496 | $2.88 footnote F3 | $19K | |
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 1,624 | $2.77 footnote F4 | $4K | |
| Pharis Mohideen - Officer | Grant or award | Ordinary Shares | 44,000 | $0.00 | - | |
| Pharis Mohideen - Officer | Grant or award | Employee Stock Option (right to buy) | 253,000 | $0.00 | - | |
| ||||||
| Kevin Michael Trapp - Officer | Grant or award | Ordinary Shares | 55,000 | $0.00 | - | |
| Kevin Michael Trapp - Officer | Grant or award | Employee Stock Option (right to buy) | 316,250 | $0.00 | - | |
| Virginie Boucinha - Officer | Grant or award | Ordinary Shares | 32,000 | $0.00 | - | |
| Virginie Boucinha - Officer | Grant or award | Employee Stock Option (right to buy) | 192,000 | $0.00 | - | |
| Daniel Tasse - Officer | Grant or award | Employee Stock Option (right to buy) | 964,000 | $0.00 | - | |
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 464 | $2.22 | $1K | |
| Daniel Tasse - Officer | Grant or award | Employee Stock Option (right to buy) | 813,200 | $0.00 | - | |
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 342 | $2.65 | $181 | |
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 565 | $2.85 | $322 | |
| Pharis Mohideen - Officer | Grant or award | Ordinary Shares | 35,000 | $0.00 | - | |
| Pharis Mohideen - Officer | Open-market sale | Ordinary Shares | 2,350 | $2.70 | $1K | |
| Pharis Mohideen - Officer | Grant or award | Employee Stock Option (right to buy) | 215,000 | $0.00 | - | |
| Virginie Boucinha - Officer | Grant or award | Ordinary Shares | 19,000 | $0.00 | - | |
| Virginie Boucinha - Officer | Grant or award | Employee Stock Option (right to buy) | 113,000 | $0.00 | - | |
DBVT insider trading FAQ
What is the latest insider trade for DBVT?
DBV Technologies S.A. (DBVT) had 1 insider filing in the last 90 days, with the most recent on 2026-07-31. The full record for DBVT runs to 12 Form 4 filings, the earliest from 2024-11-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DBVT stock?
No insider purchases of DBVT were filed in the last 90 days.
How many insiders are selling DBVT stock?
1 insider sale of DBVT was filed in the last 90 days, totaling $1K.
Where can I see DBVT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DBVT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Pharis Mohideen view on EDGAR
- - Pharis Mohideen view on EDGAR
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Pharis Mohideen view on EDGAR
- - Kevin Michael Trapp view on EDGAR
- - Virginie Boucinha view on EDGAR
- - Daniel Tasse view on EDGAR
- - Pharis Mohideen view on EDGAR
- - Daniel Tasse view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where DBVT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DBVT with a 7-day demo
- DBVT on your watchlist
- Every DBVT Form 4 filing on record
- Up to 3 months of DBVT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
